ESMC — Escalon Medical Share Price
Last trade - 00:00- $1.04m
- $1.43m
- $12.18m
- 84
- 81
- 11
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.15 | ||
| Price to Tang. Book | 1.22 | ||
| Price to Free Cashflow | 19.45 | ||
| Price to Sales | 0.1 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.92% | ||
| Return on Equity | -27.97% | ||
| Operating Margin | -0.33% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 9.63 | 9.4 | 10.47 | 10.7 | 12.18 | n/a | n/a | 1.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Escalon Medical Corp. operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications. The Company's A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. Its B-Scan is primarily a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Its UBM is a high-frequency/high-resolution ultrasound device, designed to provide information about the anterior segment of the eye. The Company's pachymeter measures the thickness of the cornea. It distributes two intraocular gas products, C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The Company also provides surgical packs and AXIS image management system software.
Directors
- Richard DePiano CHM (73)
- Richard DePiano PRE (47)
- Mark Wallace CFO (44)
- John Dogum DRC
- David Jacovini DRC (42)
- C. Todd Trusk DRC
- Fred Choate IND (75)
- Lisa Napolitano IND (48)
- Last Annual
- June 30th, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- September 27th, 2001
- Public Since
- September 11th, 1992
- No. of Shareholders
- 1,267
- No. of Employees
- 38
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 7,415,329
- Address
- 435 DEVON PARK ROAD, SUITE 824, WAYNE, 19087
- Web
- https://www.escalonmedical.com/
- Phone
- +1 6106886830
- Auditors
- Friedman LLP
Upcoming Events for ESMC
Similar to ESMC
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 20:33 UTC, shares in Escalon Medical are trading at $0.16. This share price information is delayed by 15 minutes.
Shares in Escalon Medical last closed at $0.16 and the price had moved by -22.71% over the past 365 days. In terms of relative price strength the Escalon Medical share price has underperformed the S&P500 Index by -35.13% over the past year.
There is no consensus recommendation for this security.
Escalon Medical does not currently pay a dividend.
Escalon Medical does not currently pay a dividend.
Escalon Medical does not currently pay a dividend.
To buy shares in Escalon Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.16, shares in Escalon Medical had a market capitalisation of $1.19m.
Here are the trading details for Escalon Medical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ESMC
Based on an overall assessment of its quality, value and momentum Escalon Medical is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Escalon Medical. Over the past six months, its share price has underperformed the S&P500 Index by -46.34%.
As of the last closing price of $0.16, shares in Escalon Medical were trading -17.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Escalon Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Escalon Medical's management team is headed by:
- Richard DePiano - CHM
- Richard DePiano - PRE
- Mark Wallace - CFO
- John Dogum - DRC
- David Jacovini - DRC
- C. Todd Trusk - DRC
- Fred Choate - IND
- Lisa Napolitano - IND